College of Pharmacy, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China.
Food Chem Toxicol. 2012 May;50(5):1279-87. doi: 10.1016/j.fct.2012.02.027. Epub 2012 Feb 22.
Dioscin is the major active compound in many traditional Chinese medicines (TCMs), while safety evaluation of this natural product has not yet been investigated. Therefore, the aim of this study was to evaluate the 90-day subchronic toxicity of dioscin in rats. The rats were divided into four groups and dioscin was administered orally at doses of 0, 75, 150 and 300 mg/kg/day, respectively. The toxicity of dioscin was evaluated based on clinical observations, ophthalmic examination, body weight, food and water consumption, urinalysis, hematology, clinical biochemistry and pathology. The results showed that dioscin had no subchronic toxicity in female rats and had slight subchronic toxicity in male rats. However, male rats in the 300 mg/kg/day group showed slight gastro-intestinal tract distension during the treatment period and hemolytic anemia in the hematology assessment. Compared with the control group, body weight gain was significantly decreased in male rats. Other significant changes were not associated with dioscin in the male and female groups. In conclusion, the no-observed-adverse-effect level (NOAEL) and the lowest-observed-adverse-effect level (LOAEL) of dioscin are estimated to be 300 mg/kg/day for female and male rats, respectively. Our work provides useful data for further research and new drug exploration of dioscin.
薯蓣皂苷是许多中药(TCM)中的主要活性化合物,而对这种天然产物的安全性评价尚未进行研究。因此,本研究旨在评估薯蓣皂苷在大鼠中的 90 天亚慢性毒性。大鼠分为四组,分别灌胃给予薯蓣皂苷 0、75、150 和 300mg/kg/d。根据临床观察、眼科检查、体重、食物和水的消耗、尿液分析、血液学、临床生化和病理学评估薯蓣皂苷的毒性。结果表明,薯蓣皂苷在雌性大鼠中无亚慢性毒性,在雄性大鼠中有轻微的亚慢性毒性。然而,300mg/kg/d 组的雄性大鼠在治疗期间出现轻微的胃肠道扩张,血液学评估显示溶血性贫血。与对照组相比,雄性大鼠的体重增加明显减少。雄性和雌性大鼠中其他显著变化与薯蓣皂苷无关。结论:薯蓣皂苷对雌性和雄性大鼠的无观察不良效应水平(NOAEL)和最低观察不良效应水平(LOAEL)分别估计为 300mg/kg/d。我们的工作为薯蓣皂苷的进一步研究和新药探索提供了有用的数据。